Design of Topical Moxifloxacin Mucoadhesive Nanoemulsion for the Management of Ocular Bacterial Infections

• Asıl Yazarlar: Ahmed Adel Ali Youssef (Yazar), Ruchi Thakkar (Yazar), Samir Senapati (Yazar), Poorva H. Joshi (Yazar), Narendar Dudhipala (Yazar), Soumyajit Majumdar (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2022-06-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Ocular bacterial infections can lead to serious visual disability without proper treatment. Moxifloxacin (MOX) has been approved by the US Food and Drug Administration as a monotherapy for ocular bacterial infections and is available commercially as an ophthalmic solution (0.5% <i>w</i>/...